Stock market announcement archive

LIFE – Successfully completed four weeks of longevity trials

July 17, 2024
Bergen, Norway, 17 July 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first four week of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The […]
Read more

LIFE: Cleanroom arrived in Hamburg

July 2, 2024
Bergen, Norway, July 2, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the cleanroom for automated production has arrived in Hamburg. Reference is made to Lifecare’s stock exchange announcement March 5, 2024, regarding placing a purchase order for cleanroom in connection with the […]
Read more

LIFE: Successfully completed first week of longevity trials

June 27, 2024
Bergen, Norway, 27 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first week of sensor longevity trials. Reference is made to press release 18 June 2024 when the company initiated the trials with wireless readout. Already after […]
Read more

LIFE – Longevity trials in dogs starts today

June 18, 2024
Bergen, Norway, 18 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company will starts the longevity trials in dogs today. Reference is made to stock exchange notification June 10th and June 13th, 2024. The company have improved the read-out distance […]
Read more

LIFE: Satisfied with the final results of the Rights Issue

June 14, 2024
Bergen, Norway, 14 June, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that all valid subscriptions from investors with subscription rights have been allocated in accordance with the allocation criteria set out in the prospectus for the Rights Issue. Reference is made to […]
Read more

Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission

June 14, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more

Lifecare ASA: Preliminary results of the Rights Issue

June 13, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more

LIFE – Successful in-vitro quality testing of sensor

June 13, 2024
Bergen, Norway, June 13th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company has concluded a successful in-vitro quality test of sensor for use in longevity study. Reference is made to stock exchange notification June 10th, 2024. The internal in-vitro quality […]
Read more

Lifecare ASA: Last day of the Subscription Period in the Rights Issue

June 13, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more